Literature DB >> 22906245

Impact of perioperative events on mortality after major vascular surgery in a veteran patient population.

Sonia T Orcutt1, Carlos F Bechara, George Pisimisis, Neal R Barshes, Panagiotis Kougias.   

Abstract

BACKGROUND: The aim of this study was to characterize the impact of perioperative events on long-term mortality after major vascular surgery at a single institution.
METHODS: A retrospective analysis of patients undergoing major vascular surgery was performed. The primary end point was all-cause long-term mortality. Cox regression analyses were performed to identify predictors of this outcome.
RESULTS: A total of 1,182 procedures in 706 patients were identified, including endovascular or open aortic aneurysm repair, open repair of aortoiliac or infrainguinal occlusive disease, amputations, and carotid endarterectomy. Perioperative cardiac and respiratory complications occurred in 4.9% and 1.4% of operations, respectively. On multivariate Cox regression analysis, adjusting for patient factors and operation performed, perioperative cardiac (hazard ratio, 5.3; 95% confidence interval, 1.7-15.9) and respiratory complications (hazard ratio, 5.01; 95% confidence interval, 1.48-16.98) were significant predictors of long-term mortality.
CONCLUSIONS: Although serious perioperative cardiac and respiratory events are infrequent, they have a significant impact on long-term mortality after major vascular surgery, even when adjusted for comorbidities and type of operation.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22906245     DOI: 10.1016/j.amjsurg.2012.07.014

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  1 in total

1.  Risk stratification for the development of respiratory adverse events following vascular surgery using the Society of Vascular Surgery's Vascular Quality Initiative.

Authors:  Elizabeth A Genovese; Larry Fish; Rabih A Chaer; Michel S Makaroun; Donald T Baril
Journal:  J Vasc Surg       Date:  2016-11-07       Impact factor: 4.268

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.